Mexico: US-China Final Trials for COVID-19 Vaccines


The Mexico will perform state-of-the-art clinical trials for under development vaccines for COVID19 from Johnson & Johnson and two Chinese companies, the Ministry of Foreign Affairs announced today.

Large-scale, third-phase human trials of J&J’s Janssen Pharmaceuticals’s candidate vaccine could begin in the second half of September, the company said.

Mexico will also help test vaccines from Chinese companies CanSino Biologics and Walvax Biotechnology, the ministry said in a press conference.

More than 150 vaccines are being developed and tested worldwide to stop COVID-19, with 25 of them conducting clinical trials in humans, according to the World Health Organization.

Russia is the first country to approve a vaccine against COVID-19, which it called “Sputnik V” for foreign markets, an official said today.

Johnson & Johnson began human safety testing in the US of its COVID-19 vaccine in July following the publication of details of a study in monkeys that showed that its candidate vaccine offered strong single-dose protection.

The Walvax experimental vaccine is in the early stages of testing at a military research institute in China.

The CanSino Biologics candidate vaccine is already in clinical trials. The company is also working with the National Research Council of Canada to “pave the way” for future testing in Canada, the council said in May.

Mexico is pushing for international forums, including the G20 and the United Nations, to ensure fair access to a possible vaccine.

Latin America’s second-largest economy has recorded more than 50,000 deaths from COVID-19, according to official figures, making it the third largest country in the world in deaths from the disease caused by the new coronavirus.

It ranks 13th in the Adapted List of Per capita deaths, according to Johns Hopkins University School of Medicine.


Please enter your comment!
Please enter your name here